Uji Kumiko, Tamura Shigeyuki, Takeno Atsushi, Miki Hirofumi, Kanemura Takashi, Yanai Ayako, Kobayashi Masayoshi, Yoshioka Yasumasa, Teramoto Atsuko, Nakahira Shin, Suzuki Rei, Nakata Ken, Egawa Chiyomi, Okamura Syu, Sugimoto Keishi, Takatsuka Yuichi
Department of Surgery, Kansai Rosai Hospital, Japan.
Gan To Kagaku Ryoho. 2011 Oct;38(10):1691-4.
A woman in her sixties underwent total gastrectomy for gastric cancer. The pathological diagnosis was pT3, pN3, sH0, pCY0, sP0, sM0, fStage IV. Chemotherapy with S-1 was used after surgical treatment. Because a CT scan after three courses chemotherapy showed the paraaortic lymph nodes swelling, combination chemotherapy with S-1 and docetaxel was used as a second-line chemotherapy. When the CT scan after 8 courses of this combination chemotherapy revealed multiple liver metastases, the chemotherapy was changed to CPT-11 monotherapy and paclitaxel monotherapy as the third-and fourth-line chemotherapy, respectively. In spite of those chemotherapies, the metastatic disease progressed, and therefore, combination chemotherapy with S-1 and CDDP was used as the fifth-line chemotherapy. After 6 courses of this treatment, serum CEA and CA19-9 levels dropped into the normal range. Multiple liver metastases were markedly reduced, and were considered as a partial response(PR). The patient is still alive, maintaining the effect of PR for 17 months without any adverse effects except appetite loss and vomiting of grade 2.
一名60多岁的女性因胃癌接受了全胃切除术。病理诊断为pT3、pN3、sH0、pCY0、sP0、sM0,f分期为IV期。手术治疗后采用S-1化疗。由于三疗程化疗后CT扫描显示腹主动脉旁淋巴结肿大,因此采用S-1联合多西他赛作为二线化疗。当这种联合化疗8疗程后CT扫描显示多发肝转移时,化疗分别改为CPT-11单药治疗和紫杉醇单药治疗作为三线和四线化疗。尽管进行了这些化疗,转移病灶仍进展,因此采用S-1联合顺铂作为五线化疗。该治疗6疗程后,血清CEA和CA19-9水平降至正常范围。多发肝转移明显减少,被认为是部分缓解(PR)。患者仍存活,维持PR效果17个月,除了2级食欲减退和呕吐外无任何不良反应。